• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

105
24
17
16
14

COUNTRY

17
4
3
2
2

PRICE

548
566
616
730

PUBLISHED

3
8
36
730

PRODUCT TYPE

487
233
10

Women's Health

Women are increasingly attractive to pharmaceuticals company. From adolescence to old age they come into contact with the medical services far more than men, and this gives pharmaceutical companies the opportunity to target women as a distinct customer group characterized by brand loyalty. Business opportunities are also provided by the emerging countries, where women are increasingly empowered to access reproductive and other health services.

Browse Research and Markets’ Women’s Health category to identify investment, business development and partnership opportunities across a variety of issues such as contraception, pregnancy, female infertility, dysmenorrheal, menopausal disorders, ovarian disease, vaginal atrophy, and more. Monitor the latest drug trials, enhance your clinical knowledge and explore specific markets with our reports, books, and subscriptions.

Leading players featured in our publications include Wyeth, Schering, Johnson & Johnson, and more. Show Less
Read more

PRODUCT TITLE

PharmaPoint: Postmenopausal Vaginal Atrophy - UK Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - UK Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past...

July 2013
FROM

Lung Infections - Pipeline Review, H2 2013

Lung Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Lung Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

July 2013
FROM

Pregnancy Global Clinical Trials Review, H2, 2013

Pregnancy Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Pregnancy Global Clinical Trials Review, H2, 2013" provides data on the Pregnancy clinical trial scenario. This...

July 2013
FROM

PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the...

July 2013
FROM

Vagifem (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022

Vagifem (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade,...

July 2013
FROM

Premarin (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022

Premarin (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade,...

July 2013
FROM

PharmaPoint: Postmenopausal Vaginal Atrophy - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - Spain Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the...

July 2013
FROM

Estring (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022

Estring (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade,...

July 2013
FROM

PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the...

July 2013
FROM

PharmaPoint: Postmenopausal Vaginal Atrophy - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - Japan Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the...

July 2013
FROM

PharmaPoint: Postmenopausal Vaginal Atrophy - Germany Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - Germany Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over...

July 2013
FROM

PharmaPoint: Postmenopausal Vaginal Atrophy - US Drug Forecast And Market Analysis To 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - US Drug Forecast And Market Analysis To 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past...

July 2013
FROM

PharmaPoint: Postmenopausal Vaginal Atrophy - Italy Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - Italy Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the...

July 2013
FROM

PharmaPoint: Postmenopausal Vaginal Atrophy - Current and Future Players

PharmaPoint: Postmenopausal Vaginal Atrophy - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Postmenopausal Vaginal Atrophy - Current and Future Players”....

July 2013
FROM

Vasomotor Symptoms of Menopause - Pipeline Review, H1 2013

Vasomotor Symptoms of Menopause - Pipeline Review, H1 2013 Summary 'Vasomotor Symptoms of Menopause - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

June 2013
FROM

Premature Labor (Tocolysis) - Pipeline Review, H1 2013

Premature Labor (Tocolysis) - Pipeline Review, H1 2013 Summary 'Premature Labor (Tocolysis) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

June 2013
FROM

Acute Inflammation - Pipeline Review, H1 2013

Acute Inflammation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acute Inflammation - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

May 2013
FROM

Ovarian Disease - Pipeline Review, H1 2013

Ovarian Disease – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ovarian Disease - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

May 2013
FROM

Premenstrual Syndrome - Pipeline Review, H1 2013

Premenstrual Syndrome – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Premenstrual Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

May 2013
FROM
Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics - Product Thumbnail Image

Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

The Competitive Intelligence Report Human Papilloma Virus (HPV) Vaccines & Therapeutics as of May 2013 provides a competitor analysis in the product portfolios and development pipelines of novel vaccines...

May 2013
FROM
Loading Indicator

Our Clients

Our clients' logos